Provides a narrative overview of the management of unstable angina, highlighting the roles of medical therapy, revascularization, and long-term risk modification.
Answers are grounded in this paper and cite their sources.
May guide unstable angina care decisions; leaves open the need for updated RCTs on revascularization timing.
The primary goals in treatment of unstable angina are to relieve pain and prevent or limit myocardial infarction or ischemia. Patients with distinct, rapid progression of their usual angina pattern should be admitted to a coronary care unit and given heparin and intravenous nitrates as well as aspirin. Cardioselective beta blockers should also be administered when there are no contraindications. Intravenous thrombolytic agents are indicated in patients with objective evidence of ischemia who fit criteria for this therapy. However, thrombolysis is not advocated for routine treatment of unstable angina. Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting should be considered--depending on the location, age, and morphology of the culprit lesion and the degree of left ventricular dysfunction--in patients who have refractory or recurrent ischemia despite aggressive medical therapy. However, in general, high-technology interventions are not a substitute for long-term regimens, such as risk-factor and lifestyle modification, daily aspirin, and pharmacologic therapies aimed at maximizing cardiac function.
No takes yet. Share an insight, caveat, or question.
Blake-Inada et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: